<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05089721</url>
  </required_header>
  <id_info>
    <org_study_id>ecd9b925a955474783d32b99b7f21</org_study_id>
    <nct_id>NCT05089721</nct_id>
  </id_info>
  <brief_title>Questionnaire for Obstetricians and Anesthesiologist</brief_title>
  <official_title>Questionnaire for Evaluation of Uterotonic Usage Habits of Obstetricians and Anesthesiologist</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research was planned as a face-to-face survey evaluation. The questionnaire will be&#xD;
      applied to obstetricians and anesthesiologists working in public and private hospitals. The&#xD;
      universe of the research will be selected by simple random sampling method, and the total&#xD;
      number of people who will participate is planned to be 200, approximately 100 from each of&#xD;
      the two branches. Our survey consists of 5 parts structurally. Demographic data, rate of&#xD;
      cesarean section and postpartum hemorrhage, uterotonic agent preferences in low/high risk&#xD;
      cesarean section surgeries, the preference for second-line uterotonic agents, and the dose&#xD;
      preferences of uterotonic agents.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Uterotonic usage habits in postpartum hemorrhage</measure>
    <time_frame>3 months</time_frame>
    <description>to learn the uterotonic use preferences of both obstetricians and anesthesiologists in postpartum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uterotonic usage habits in elective cesearean section</measure>
    <time_frame>3 months</time_frame>
    <description>to learn the uterotonic use preferences of both obstetricians and anesthesiologists in elective cesarean section</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Uterine Bleeding</condition>
  <condition>Atony, Uterine</condition>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>Anesthesiologist</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Obstetricians</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Through national obstetrics and anesthesiologist associations, the survey will be sent to&#xD;
        the participant's e-mail addresses. Those who answer the questionnaire will be included in&#xD;
        the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: obstetricians and anesthesiologists who want to participate in the&#xD;
        survey&#xD;
&#xD;
        Exclusion Criteria: the ones who do not want to participate&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gazi University School of Medicine</name>
      <address>
        <city>Ankara</city>
        <zip>06500</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Thorneloe B, Carvalho JCA, Downey K, Balki M. Uterotonic drug usage in Canada: a snapshot of the practice in obstetric units of university-affiliated hospitals. Int J Obstet Anesth. 2019 Feb;37:45-51. doi: 10.1016/j.ijoa.2018.09.002. Epub 2018 Sep 12.</citation>
    <PMID>30396679</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 11, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Selin Erel</investigator_full_name>
    <investigator_title>Attending</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Uterine Inertia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>overall results of survey will be shared, individual answers of participants wont be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

